The Effect of Cardiovascular Medications on Disease-Related Outcomes in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis

The Effect of Cardiovascular Medications on Disease-Related Outcomes in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis

Background: Multiple studies have revealed that idiopathic pulmonary fibrosis (IPF) patients are more at risk for cardiovascular diseases and that many IPF patients receive cardiovascular medications like statins, angiotensin-converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB), an...

Full description

Bibliographic Details
Main Authors: Wan-Tong Zhang, Xu-Jie Wang, Chun-Miao Xue, Xin-Yu Ji, Lin Pan, Wei-Liang Weng, Qiu-Yan Li, Guo-Dong Hua, Bao-Chen Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Pharmacology
Subjects:
idiopathic pulmonary fibrosis
ACEI/ARB
statin
anticoagulants
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.771804/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.771804/full

Similar Items